Literature DB >> 33437008

Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017-2020.

Nungruthai Suntronwong1, Sirapa Klinfueng1, Sumeth Korkong1, Preeyaporn Vichaiwattana1, Thanunrat Thongmee1, Sompong Vongpunsawad1, Yong Poovorawan2.   

Abstract

We monitored the circulating strains and genetic variation among seasonal influenza A and B viruses in Thailand between July 2017 and March 2020. The hemagglutinin gene was amplified and sequenced. We identified amino acid (AA) changes and computed antigenic relatedness using the Pepitope model. Phylogenetic analyses revealed multiple clades/subclades of influenza A(H1N1)pdm09 and A(H3N2) were circulating simultaneously and evolved away from their vaccine strain, but not the influenza B virus. The predominant circulating strains of A(H1N1)pdm09 belonged to 6B.1A1 (2017-2018) and 6B.1A5 (2019-2020) with additional AA substitutions. Clade 3C.2a1b and 3C.2a2 viruses co-circulated in A(H3N2) and clade 3C.3a virus was found in 2020. The B/Victoria-like lineage predominated since 2019 with an additional three AA deletions. Antigenic drift was dominantly facilitated at epitopes Sa and Sb of A(H1N1)pdm09, epitopes A, B, D and E of A(H3N2), and the 120 loop and 190 helix of influenza B virus. Moderate computed antigenic relatedness was observed in A(H1N1)pdm09. The computed antigenic relatedness of A(H3N2) indicated a significant decline in 2019 (9.17%) and 2020 (- 18.94%) whereas the circulating influenza B virus was antigenically similar (94.81%) with its vaccine strain. Our findings offer insights into the genetic divergence from vaccine strains, which could aid vaccine updating.

Entities:  

Year:  2021        PMID: 33437008      PMCID: PMC7803983          DOI: 10.1038/s41598-020-80895-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  46 in total

1.  Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.

Authors:  S Nakajima; E Nobusawa; K Nakajima
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

2.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

Review 3.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

Authors:  Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean
Journal:  Lancet Infect Dis       Date:  2016-04-06       Impact factor: 25.071

4.  Genetic and antigenic characterization of hemagglutinin of influenza A/H3N2 virus from the 2015 season in Thailand.

Authors:  Nipaporn Tewawong; Nungruthai Suntronwong; Preeyaporn Vichiwattana; Sompong Vongpunsawad; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Virus Genes       Date:  2016-05-04       Impact factor: 2.332

5.  A global map of hemispheric influenza vaccine recommendations based on local patterns of viral circulation.

Authors:  Wladimir J Alonso; Christine Yu; Cecile Viboud; Stephanie A Richard; Cynthia Schuck-Paim; Lone Simonsen; Wyller A Mello; Mark A Miller
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

6.  Complete mapping of viral escape from neutralizing antibodies.

Authors:  Michael B Doud; Scott E Hensley; Jesse D Bloom
Journal:  PLoS Pathog       Date:  2017-03-13       Impact factor: 6.823

7.  Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.

Authors:  Danuta M Skowronski; Siobhan Leir; Suzana Sabaiduc; Michelle Murti; James A Dickinson; Romy Olsha; Jonathan B Gubbay; Matthew A Croxen; Hugues Charest; Tracy Chan; Nathalie Bastien; Yan Li; Mel Krajden; Gaston De Serres
Journal:  Euro Surveill       Date:  2019-01

8.  Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine.

Authors:  Scott Epperson; C Todd Davis; Lynnette Brammer; Anwar Isa Abd Elal; Noreen Ajayi; John Barnes; Alicia P Budd; Erin Burns; Peter Daly; Vivien G Dugan; Alicia M Fry; Yunho Jang; Sara Jo Johnson; Krista Kniss; Rebecca Kondor; Lisa A Grohskopf; Larisa Gubareva; Angiezel Merced-Morales; Wendy Sessions; James Stevens; David E Wentworth; Xiyan Xu; Daniel Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-10-11       Impact factor: 17.586

9.  Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.

Authors:  Seth J Zost; Kaela Parkhouse; Megan E Gumina; Kangchon Kim; Sebastian Diaz Perez; Patrick C Wilson; John J Treanor; Andrea J Sant; Sarah Cobey; Scott E Hensley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

10.  Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.

Authors:  Angela Rose; Esther Kissling; Hanne-Dorthe Emborg; Amparo Larrauri; Jim McMenamin; Francisco Pozo; Ramona Trebbien; Clara Mazagatos; Heather Whitaker; Marta Valenciano
Journal:  Euro Surveill       Date:  2020-03
View more
  4 in total

1.  Genome characterization and mutation analysis of human influenza A virus in Thailand.

Authors:  Somruthai Rattanaburi; Vorthon Sawaswong; Pattaraporn Nimsamer; Oraphan Mayuramart; Pavaret Sivapornnukul; Ariya Khamwut; Prangwalai Chanchaem; Kritsada Kongnomnan; Nungruthai Suntronwong; Yong Poovorawan; Sunchai Payungporn
Journal:  Genomics Inform       Date:  2022-06-30

2.  Expanding Mouse-Adapted Yamagata-like Influenza B Viruses in Eggs Enhances In Vivo Lethality in BALB/c Mice.

Authors:  Matthew J Pekarek; Erika M Petro-Turnquist; Adam Rubrum; Richard J Webby; Eric A Weaver
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

3.  Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.

Authors:  Victor Daniel Miron; Leontina Bănică; Oana Săndulescu; Simona Paraschiv; Marius Surleac; Dragoș Florea; Ovidiu Vlaicu; Petre Milu; Anca Streinu-Cercel; Anuta Bilașco; Dan Oțelea; Daniela Pițigoi; Adrian Streinu-Cercel; Anca Cristina Drăgănescu
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

4.  Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk.

Authors:  Jonathan Tin Lai Cheung; Tim K Tsang; Hui-Ling Yen; Ranawaka A P M Perera; Chris Ka Pun Mok; Yong Ping Lin; Benjamin J Cowling; Malik Peiris
Journal:  Emerg Infect Dis       Date:  2022-05       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.